MDxHealth SA announced the appointment of Michael Holder to its Board of Directors, where he will serve as the Chair of the Audit Committee. Mr. Holder brings over 30 years of diverse experience across the biotech, medtech, health tech, pharma, and wellness industries, including nine board, four CEO, and five CFO roles.
Mr. Holder's extensive expertise in corporate strategy, M&A, corporate governance, and financial acumen is expected to be valuable as MDxHealth continues its growth trajectory in the urology markets. He takes the seat of Regine Slagmulder, whose term on the board concluded in May.
Concurrently, the company announced that Ron Kalfus has resigned from his position as Chief Financial Officer to pursue other opportunities. Mr. Kalfus will continue to serve in his role until his departure on July 30, 2025, after which Scott McMahan, Vice President of Finance and Accounting, will assume interim CFO responsibilities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.